Insider Transactions in Q1 2023 at Inozyme Pharma, Inc. (INZY)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 31
2023
|
Axel Bolte |
BUY
Grant, award, or other acquisition
|
Direct |
4,806
+1.77%
|
$9,612
$2.21 P/Share
|
Mar 31
2023
|
Sanjay Subramanian SVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
979
+3.37%
|
$1,958
$2.21 P/Share
|
Mar 29
2023
|
Robert Lorne Hopfner |
BUY
Open market or private purchase
|
Indirect |
344,592
+9.68%
|
$1,378,368
$4.54 P/Share
|
Mar 28
2023
|
Robert Lorne Hopfner |
BUY
Open market or private purchase
|
Indirect |
156,766
+5.18%
|
$627,064
$4.16 P/Share
|
Mar 27
2023
|
Robert Lorne Hopfner |
BUY
Open market or private purchase
|
Indirect |
51,074
+1.85%
|
$153,222
$3.7 P/Share
|